Screener
AnaptysBio, Inc. ANAB Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
| Line item | March 31, 2026(unaudited) | December 31, 2025 |
|---|---|---|
| Property and equipment, net | 1,280 | 1,370 |
| Operating lease right-of-use assets | 12,039 | 12,519 |
| Other long-term assets | 256 | 256 |
| Total assets | $329,684 | $364,395 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $7,517 | $3,871 |
| Accrued expenses | 32,065 | 32,674 |
Item 1. Consolidated Financial Statements
FAQ
- What is AnaptysBio, Inc.'s total assets?
- AnaptysBio, Inc. (ANAB) reported total assets of $329.68M in Q1 2026.
- How has AnaptysBio, Inc.'s total assets changed year-over-year?
- AnaptysBio, Inc.'s total assets decreased by 21.9% year-over-year, from $422.05M to $329.68M.
- What is the long-term trend for AnaptysBio, Inc.'s total assets?
- Over 5 years (2020 to 2025), AnaptysBio, Inc.'s total assets has grown at a -2.6% compound annual growth rate (CAGR), from $416.55M to $364.4M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about AnaptysBio, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude